ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

44 hedge funds and large institutions have $2.75M invested in Zynerba Pharmaceuticals, Inc in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38.1K
2
+$14K
3
+$8K
4
RJFSA
Raymond James Financial Services Advisors
Florida
+$6.11K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.91K

Top Sellers

1
-$339K
2
-$116K
3
-$103K
4
IEFM
IQ EQ Fund Management
Ireland
-$65.1K
5
Millennium Management
Millennium Management
New York
-$44.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3.23K
27
$2.61K
28
$2K
29
$1.96K
30
$1K
31
$447
32
$215
33
$151
34
$93
35
$86
36
$75
37
$43
38
$43
39
$22
40
$1
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2